CN102846882A - Chinese medicinal composition for reducing blood sugar - Google Patents
Chinese medicinal composition for reducing blood sugar Download PDFInfo
- Publication number
- CN102846882A CN102846882A CN2012102812442A CN201210281244A CN102846882A CN 102846882 A CN102846882 A CN 102846882A CN 2012102812442 A CN2012102812442 A CN 2012102812442A CN 201210281244 A CN201210281244 A CN 201210281244A CN 102846882 A CN102846882 A CN 102846882A
- Authority
- CN
- China
- Prior art keywords
- blood
- sugar lowering
- parts
- chinese medicinal
- blood sugar
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention provides a Chinese medicinal composition for reducing blood sugar, which comprises the following components in parts by weight: 5 parts of epipremnum aureum flower, 2 to 3 parts of pseudo-ginseng flower, 2 to 3 parts of snow lotus camellias, and 1 to 4 parts of fragrant solomonseal rhizome or fiveleaf gynostemma herb. The composition also can comprise hawthorn and/or cassia seed. The Chinese medicinal composition has a remarkable effect in reducing blood sugar, and has the advantages of safety, no toxic or side effect, sequential sugar reduction and stable curative effect can be used for complete treatment, can be drunk as long as the Chinese medicinal is mixed with boiled water, and is convenient to take.
Description
Technical field
The present invention relates to treat the diabetes medicament technical field, refer to especially a kind of blood-sugar lowering tcm drug compositions.
Background technology
The chronic complicating diseases of diabetes is main causes that patient causes death, disables.The genesis mechanism of its complication is very complicated, oneself forms Chinese scholars the aspect such as upper removing imbalance and is studied from albumen nonenzymatic glycosylation, polyhydric alcohol path Developmental and Metabolic Disorder, free radical, and think that these several respects influence each other, but still owe desirable to the treatment means of chronic complicating diseases, now mainly be conceived to control in the prevention of blood glucose, early diagnosis, risk factor.Main Function such as lattice train urea is to promote insulin secretion, also can promote peripheral tissues to the effect of insulin, but it is durative action preparation, easily accumulates in vivo, can cause intractable hypoglycemic generation.It is obvious to blood sugar decreasing effect, but there is evidence to show the generation and the development that prevent or delay complication is not had obvious effect.
Hyperlipidemia, hypertension and hyperglycemia are called as " three-hypers ", are the principal elements that threatens diabetes patient's health and life.The three is closely related, and hyperlipidemia can increase the weight of diabetes, so the diabetes patient also needs to regulate blood fat except the treatment hyperglycemia, is the key that reduces diabetes patient's mortality rate and disability rate.If the meaning is that diabetes patient's blood fat is controlled well, blood glucose also can be controlled preferably " blood fat reducing of blood sugar lowering elder generation, blood lipid and reducing blood sugar self-balancing ".The prerequisite of blood sugar lowering is blood fat reducing.The diabetes patient should note transferring blood fat, this be because: diabetes and hyperlipidemia complications more easily causes apoplexy, coronary heart disease, limb necrosis, retinopathy, nephropathy, neuropathy etc., and the long term complication of these diabetes is to cause the disabled or too early main causes of death of diabetics.
Existing blood sugar lowering method generally all is to use simple insulin secretion or exogenous increase islets of langerhans and usually control blood glucose, can't realize the self regulation of blood glucose at all, and long-term prescription blood glucose is fluctuated, and drug side effect is large.
Summary of the invention
The present invention is directed to the defective of prior art, propose a kind of taking convenience, in proper order blood sugar lowering, stable curative effect, thorough treatment, blood-sugar lowering tcm drug compositions without any side effects.
Technical scheme of the present invention is achieved in that
A kind of blood-sugar lowering tcm drug compositions comprises the component of following weight portion:
Scindapsus aureus originates in the Tibet cold zone, and cold nature, trophophase only have more than 40 day, the peculiar precious herbaceous plant in Tibet.Scindapsus aureus is to diabetes, coronary heart disease, and hypertension, the various vascular inflammations such as hyperlipidemia have significant curative effect.Scindapsus aureus can reducing blood sugar and blood fat, and mainly to diabetes, fatty liver, coronary heart disease, overweight people, hyperlipidemia, various vascular inflammations have good auxiliary therapeutic action.In addition eyes and liver are played good health-care effect.
Rhizoma Polygonati Odorati property is done, and is slightly cold, and returns lung, stomach warp, energy nourishing YIN and moistening the lung, reinforcing stomach reg fluid.Contain polysaccharide, tannin, phlegmatic temperament, cardiac glycoside etc. in the Rhizoma Polygonati Odorati." book on Chinese herbal medicine justice ": " control lung dryness of the stomach heat, body fluid dries up, the diseases such as thirsty dry sensation in the pharynx, and excessiveness of stomach-fire, dry thirsty rapid digestion of food, polyorexia person, You Youjie effect ".These product have the laboratory animal of promotion antibody and generate, improve phagocytic percentage and the phagocytic index of macrophage, promote interferon synthetic, suppress growth of bacillus tubercle, blood sugar lowering, blood fat reducing is alleviated atherosclerotic plaque and is formed, and makes peripheral blood vessel and coronary dilation, prolong hypoxia endurance time, heart tonifying, antioxidation, the anti-ageing effect of waiting for a long time.Especially on the impact of blood glucose, to the rabbit intramuscular injection, can make blood sugar increasing with 0.5g/kg Rhizoma Polygonati Odorati preserved material.
Gypenoside has dual regulation, and Herb Gynostemmae Pentaphylli total glycosides can be expanded the peripheral blood blood vessel, thereby obvious hypotensive activity etc. is arranged.
Flower of Radix Notoginseng has blood fat reducing, blood pressure lowering, anticancer, improves the scheming oxygen delivery capacity, the effect of enhancing human body immunity function.
As preferred technical scheme, described blood-sugar lowering tcm drug compositions also comprises Fructus Crataegi.
As preferred technical scheme, described blood-sugar lowering tcm drug compositions also comprises Semen Cassiae.
As preferred technical scheme, the component that described blood-sugar lowering tcm drug compositions comprises and the weight portion of each component are as follows:
As preferred technical scheme, the component that described blood-sugar lowering tcm drug compositions comprises and the weight portion of each component are as follows:
As preferred technical scheme, the component that described blood-sugar lowering tcm drug compositions comprises and the weight portion of each component are as follows:
Chinese medicine composition of the present invention gets final product according to the preparation method of routine, that is:
Raw material is sterilized, grinds and sieves according to common process, be distributed into bag, get product.
Beneficial effect
Chinese medicine composition blood sugar decreasing effect of the present invention is obvious, safe without toxic side effect, and in proper order blood sugar lowering, stable curative effect, thorough treatment, boiled water brews namely drinkable, taking convenience.
The specific embodiment
The below will be clearly and completely described the technical scheme in the embodiment of the invention, and obviously, described embodiment only is the present invention's part embodiment, rather than whole embodiment.Based on the embodiment among the present invention, those of ordinary skills belong to the scope of protection of the invention not making the every other embodiment that obtains under the creative work prerequisite.
Chinese medicine composition among the present invention is with Scindapsus aureus, and two kinds of medical materials of Rhizoma Polygonati Odorati or Herb Gynostemmae Pentaphylli are main, is aided with flower of Radix Notoginseng, the Herba Saussureae Involueratae Flos Camelliae Japonicae of fat-reducing effect, can also add Fructus Crataegi and/or Semen Cassiae.Above-mentioned raw materials is commercially available.These raw materials sterilize, grind and sieve through common process, are distributed into bag, get product.The gained finished product brewed to drink as a tea with boiled water every day get final product.Synergism between each material is better, and hypoglycemic effect is obvious.
Embodiment 1
Blood-sugar lowering tcm drug compositions 1 comprises following component and content:
Be prepared as follows:
The raw material of said ratio is sterilized, grinds and sieves according to common process, be distributed into bag, get product.
Embodiment 2
Blood-sugar lowering tcm drug compositions 2 comprises following component and content:
Be prepared as follows:
The raw material of said ratio is sterilized, grinds and sieves according to common process, be distributed into bag, get product.
Embodiment 3
Blood-sugar lowering tcm drug compositions 3 comprises following component and content:
Be prepared as follows:
The raw material of said ratio is sterilized, grinds and sieves according to common process, be distributed into bag, get product.
Give respectively the A that has just fallen ill group with the product among the embodiment 1, take the B group of blood sugar lowering Western medicine, the C group that has Western medicine and beat insulin; Wherein A group number is 100 people, and B group number is 100 people, and C group number also is 100 people; Dose is every bag 15g, and boiled water soaks, one day one bag.
Effect is as follows:
The A group: on average take blood glucose decline 10 day after tomorrow, 20 days steadily.
The B group: on average take drug withdrawal after 10 days, blood glucose descended in 20 days.
The C group: on average take and stopped insulin in 20 days, drug withdrawal in 60 days, 80 days blood sugar lowering can be down to normal value in 3 months.
Total effective rate reaches more than 90%.
The obvious hypoglycemic effect that the product of embodiment 2-3 is also obtained.
As from the foregoing, the Chinese medicine composition blood sugar decreasing effect is obvious, selects the equal safe without toxic side effect of raw material.In proper order blood sugar lowering, stable curative effect, thorough treatment, without any side effects.Product of the present invention directly brews namely drinkable with boiled water, can drink as a tea taking convenience.
The above only is preferred embodiment of the present invention, and is in order to limit the present invention, within the spirit and principles in the present invention not all, any modification of doing, is equal to replacement, improvement etc., all should be included within protection scope of the present invention.
Claims (6)
2. a kind of blood-sugar lowering tcm drug compositions according to claim 1 is characterized in that, described blood-sugar lowering tcm drug compositions also comprises Fructus Crataegi.
3. a kind of blood-sugar lowering tcm drug compositions according to claim 1 and 2 is characterized in that, described blood-sugar lowering tcm drug compositions also comprises Semen Cassiae.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210281244.2A CN102846882B (en) | 2012-08-09 | 2012-08-09 | Chinese medicinal composition for reducing blood sugar |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210281244.2A CN102846882B (en) | 2012-08-09 | 2012-08-09 | Chinese medicinal composition for reducing blood sugar |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102846882A true CN102846882A (en) | 2013-01-02 |
CN102846882B CN102846882B (en) | 2015-03-25 |
Family
ID=47394127
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210281244.2A Expired - Fee Related CN102846882B (en) | 2012-08-09 | 2012-08-09 | Chinese medicinal composition for reducing blood sugar |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102846882B (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104431078A (en) * | 2014-12-02 | 2015-03-25 | 范建武 | Blood-glucose-lowering plant tea and preparation method thereof |
CN104472798A (en) * | 2014-11-30 | 2015-04-01 | 林国友 | Herb tea capable of lowering hyperglycemia and preparation method thereof |
CN110432349A (en) * | 2019-08-20 | 2019-11-12 | 李林奇 | It is a kind of can antihypertensive, hyperlipidemia, hyperglycemia tea production method |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1489920A (en) * | 2002-10-15 | 2004-04-21 | 刘玉峰 | Chinese herbal medicinal tea and preparation thereof |
CN101147513A (en) * | 2006-09-20 | 2008-03-26 | 杨光孝 | Pseudo-ginseng diabetic tea |
CN101181446A (en) * | 2007-11-23 | 2008-05-21 | 广东工业大学 | Application of sitsang scindapsus aureus flower as well as extract thereof in the preparation of diabetes medicament |
-
2012
- 2012-08-09 CN CN201210281244.2A patent/CN102846882B/en not_active Expired - Fee Related
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1489920A (en) * | 2002-10-15 | 2004-04-21 | 刘玉峰 | Chinese herbal medicinal tea and preparation thereof |
CN101147513A (en) * | 2006-09-20 | 2008-03-26 | 杨光孝 | Pseudo-ginseng diabetic tea |
CN101181446A (en) * | 2007-11-23 | 2008-05-21 | 广东工业大学 | Application of sitsang scindapsus aureus flower as well as extract thereof in the preparation of diabetes medicament |
Non-Patent Citations (2)
Title |
---|
朱志远等: "中医药治疗2型糖尿病的研究进展", <<四川中医>>, vol. 29, no. 5, 31 May 2011 (2011-05-31), pages 48 - 52 * |
玲瑾: "春天来了去吃"花"", <<时代风采>>, no. 02, 29 February 2004 (2004-02-29), pages 36 - 37 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104472798A (en) * | 2014-11-30 | 2015-04-01 | 林国友 | Herb tea capable of lowering hyperglycemia and preparation method thereof |
CN104431078A (en) * | 2014-12-02 | 2015-03-25 | 范建武 | Blood-glucose-lowering plant tea and preparation method thereof |
CN110432349A (en) * | 2019-08-20 | 2019-11-12 | 李林奇 | It is a kind of can antihypertensive, hyperlipidemia, hyperglycemia tea production method |
Also Published As
Publication number | Publication date |
---|---|
CN102846882B (en) | 2015-03-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102988638B (en) | Cyclocarya paliurus blood-lipid and blood-sugar reducing health-care tea and preparation method thereof | |
CN102784295B (en) | Health-care preparation formula for improving female climacteric syndrome and preparation method of same | |
CN102293273A (en) | Health tea capable of adjusting blood pressure, blood sugar and blood fat and preventing thrombus and apoplexy | |
CN104740308B (en) | A kind of hypoglycemic oral liquid of medical bio and preparation method thereof | |
CN103859369A (en) | Health-preserving health food formula beneficial for beautifying and enlarging breasts and preparation method thereof | |
CN103169793B (en) | Medicine for treating hypertension, hyperlipoidemia and diabetes mellitus | |
CN105454576A (en) | Jasmine-flower-comprising assorted Chinese herbal tea and preparation method thereof | |
CN101518595A (en) | Medical composition with functions of lowering lipid, reducing fat and oxidation resistance and preparation method thereof | |
CN102366604A (en) | Sobering traditional Chinese medicinal preparation and its preparation method | |
CN103181434A (en) | Comfortable health-care tea and preparation method thereof | |
CN101711798A (en) | Preparation used for lowering blood fat and lowering blood sugar | |
CN102846882B (en) | Chinese medicinal composition for reducing blood sugar | |
CN101491338A (en) | Nutrient food capable of improving sleep and preparation method thereof | |
CN109395028A (en) | A kind of Ge Jingjia ginseng wine formula and preparation method preventing, treating three high diseases | |
CN108813501A (en) | With the relieving cough and reducing sputum health honey paste relievingd asthma and adjust function of human body of clearing heat and moistening lung | |
CN103520302B (en) | Sea-buckthorn leaf anti-fatigue capsule and preparation method thereof | |
CN101601814A (en) | A kind of Chinese medicinal capsule for the treatment of diabetes | |
CN101564431B (en) | Chinese medicament preparation for keeping fit, resisting fatigue and fighting senium and producing method thereof | |
CN101062283B (en) | Tea for reducing blood sugar and its preparing method | |
CN106260348A (en) | A kind of SANYE Jingya Daipao Teas and preparation method thereof | |
CN102139057B (en) | Healthcare tea capable of lowering glucose | |
CN106138900A (en) | Auxiliary treats hyperglycemia and the compositions of diabetic complication and application thereof | |
CN104815140A (en) | Composition for preventing or/and treating diabetes and preparation method of composition | |
CN110313612A (en) | A kind of tonifying Qi functional nutrient food kidney nourishing | |
CN108310212A (en) | A kind of drug and its preparation method and application for anti-aging |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C56 | Change in the name or address of the patentee | ||
CP02 | Change in the address of a patent holder |
Address after: 201620, No. 1, No. 99, Lane 11, Xilin South Road, Shanghai, Songjiang District Patentee after: SHANGHAI SHOUYE BIOTECHNOLOGY Co.,Ltd. Address before: 1, 27, Lane 1470, 201620 Yang Yang Bei Road, Shanghai, Songjiang District, -1 Patentee before: Shanghai Shouye Biotechnology Co.,Ltd. |
|
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20150325 Termination date: 20210809 |